Harry F. Hixson, Jr.
2013
In 2013, Harry F. Hixson, Jr. earned a total compensation of $214K as Interim Chief Executive Officer and Director at Arena Pharmaceuticals.
Compensation breakdown
| Stock Awards | $164,994 |
|---|---|
| Other | $49,000 |
| Total | $213,994 |
Hixson received $165K in stock awards, accounting for 77% of the total pay in 2013.
Hixson also received $49K in other compensation.
Rankings
In 2013, Harry F. Hixson, Jr.'s compensation ranked 11,497th out of 12,286 executives tracked by ExecPay. In other words, Hixson earned more than 6.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,497 out of 12,286 | 6th |
Division Manufacturing | 4,316 out of 4,612 | 6th |
Major group Chemicals And Allied Products | 1,370 out of 1,466 | 7th |
Industry group Drugs | 1,088 out of 1,160 | 6th |
Industry Pharmaceutical Preparations | 840 out of 890 | 6th |
Source: SEC filing on April 28, 2016.
Hixson's colleagues
We found five more compensation records of executives who worked with Harry F. Hixson, Jr. at Arena Pharmaceuticals in 2013.
2013
Jack Lief
Arena Pharmaceuticals
Chief Executive Officer
2013
Dominic Behan
Arena Pharmaceuticals
Chief Scientific Officer
2013
Steven Spector
Arena Pharmaceuticals
General Counsel
2013
William Shanahan
Arena Pharmaceuticals
Chief Medical Officer
2013
Robert Hoffman
Arena Pharmaceuticals